UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.
To continue reading click here
Repurposed cancer drug shows promise against drug-resistant herpes infections
